Evidence map›Paper›PMID 31440697›Full record

ArticleKidney international reports2019

Text Messaging for Disease Monitoring in Childhood Nephrotic Syndrome.

Chia-Shi Wang, Jonathan P Troost, Larry A Greenbaum, Tarak Srivastava, Kimberly Reidy, Keisha Gibson, Howard Trachtman, John D Piette, Christine B Sethna, Kevin Meyers and 12 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 16 institutions in 1 country.

Chia-Shi WangDepartment of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Jonathan P TroostDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
Larry A GreenbaumDepartment of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Tarak SrivastavaDepartment of Pediatrics, Children's Mercy Hospital and University of Missouri at Kansas City, Kansas City, Missouri, USA.
Kimberly ReidyDepartment of Pediatrics, Montefiore Medical Center, New York, New York, USA.
Keisha GibsonDepartment of Medicine and Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.
Howard TrachtmanDepartment of Pediatrics, NYU School of Medicine, New York, New York, USA.
John D PietteDepartment of Health Behavior & Health Education, University of Michigan, Ann Arbor, Michigan, USA.
Christine B SethnaDepartment of Pediatrics, Cohen Children's Medical Center of New York, New Hyde Park, New York, USA.
Kevin MeyersDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Katherine M DellDepartment of Pediatrics, Case Western Reserve University, Cleveland Clinic Children's, Cleveland, Ohio, USA.
Cheryl L TranDepartment of Pediatrics, Mayo Clinic, Rochester, Minnesota, USA.
Suzanne VentoDepartment of Pediatrics, NYU School of Medicine, New York, New York, USA.
Krishna KallemDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Emily HerreshoffDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
Sangeeta HingoraniDepartment of Pediatrics, Seattle Children's Hospital, Seattle, Washington, USA.
Kevin LemleyDepartment of Pediatrics, Children's Hospital-LA, Los Angeles, California, USA.
Gia OhDepartment of Pediatrics, Stanford University, Palo Alto, California, USA.
Elizabeth BrownDepartment of Pediatrics, UT Southwestern Medical Center, Dallas, Texas, USA.
Jen-Jar LinDepartment of Pediatrics, Wake Forest University, Winston-Salem, North Carolina, USA.
Frederick KaskelDepartment of Pediatrics, Montefiore Medical Center, New York, New York, USA.
Debbie S GipsonDepartment of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan, USA.
University of Michigan–Ann Arbor · USChildren's Hospital of Philadelphia · USMontefiore Medical Center · USNew York University · USCase Western Reserve University · USChildren's Healthcare of Atlanta · USChildren's Hospital of Los Angeles · USChildren's Mercy Hospital · USCohen Children's Medical Center · USEmory University · USMayo Clinic · USSeattle Children's Hospital · USStanford University · USThe University of Texas Southwestern Medical Center · USUniversity of North Carolina at Chapel Hill · USWake Forest University · US

Funding

Training Program in Clinical & Translationa Research in Human Glomerular DiseaseU54DK083912 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRETZLER, MATTHIAS · 2009 to 2023
$20.3M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
NIDDK NIH HHS P30 DK092926NIDDK NIH HHS U54 DK083912
6 · The paper itself

Abstract

introductionThere is limited information on effective disease monitoring for prompt interventions in childhood nephrotic syndrome. We examined the feasibility and effectiveness of a novel text messaging system (SMS) for disease monitoring in a multicenter, prospective study.

methodsA total of 127 patients <19 years with incident nephrotic syndrome were enrolled in the ongoing Nephrotic Syndrome Study Network between June 2015 and March 2018. Text messages soliciting home urine protein results, symptoms, and medication adherence were sent to a designated caregiver (

resultsA total of 119 of 127 (94%) patients agreed to SMS monitoring. Retention rate was 94%, with a median follow-up of 360 days (interquartile range [IQR] 353-362). Overall engagement was high, with a median response rate of 87% (IQR, 68-97). Concordance between SMS-captured home urine protein results and edema status with same-day in-person study visit was excellent (kappa values 0.88 and 0.92, respectively). SMS detected a total of 108 relapse events compared with 41 events captured by scheduled visits. Median time to remission after enrollment was 22 days as captured by SMS versus 50 days as captured by scheduled visits.

conclusionSMS was well accepted by caregivers and adolescent patients and reliably captured nephrotic syndrome disease activity between clinic visits. Additional studies are needed to explore the impact of SMS on disease outcomes.

Indexed as

caregiverschildrenhealth statusmobile healthnephrotic syndrometext messaging

Identifiers

PMID31440697
PMCPMC6698307
OpenAlexW2944536518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.